Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Outlook Therapeutics (41O.F) Q2 2024 Earnings
41O.F
15
May
Confirmed
Q2 2024
-1.42
-1.23
-1.03
-0.84
Details
Expected EPS
-0.8355793680000001
Actual EPS
-1.423396
Surprise EPS
-0.59
Surprise Percent
+70.35%
Description
Outlook Therapeutics (41O.F) has reported earnings of -1.423396 per share for Q2 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login